+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Completed

Phase 3
Age: 18Years - 74Years
All Genders
ID00000507

Intravenous Streptokinase in Acute Myocardial Infarction

Led by University of Washington · Updated on 2016-02-10

N/A

Participants Needed

N/A

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

To determine whether the administration of intravenous streptokinase (SK) early in the course of acute, transmural myocardial infarction would limit myocardial damage.

CONDITIONS

Brief Title

Intravenous Streptokinase in Acute Myocardial Infarction

Trial Site Locations

Site Locations not provided

Location information for this trial is currently unavailable.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here